Association of MGMT Promoter Methylation Status With Survival Outcomes in Glioma

This secondary analysis of the NRG Oncology/RTOG 0424 randomized clinical trial examines the proportion of patients with MGMT promoter methylation and its association with survival outcomes in high-risk glioma treated with radiotherapy and temozolomide.

https://ift.tt/2IACzHU